Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
miR-301a expression: A prognostic marker for prostate cancer.
Damodaran C, Das TP, Papu John AM, Suman S, Kolluru V, Morris TJ, Faber EN, Rai SN, Messer JC, Alatassi H, Ankem MK. Damodaran C, et al. Urol Oncol. 2016 Aug;34(8):336.e13-20. doi: 10.1016/j.urolonc.2016.03.009. Epub 2016 Apr 26. Urol Oncol. 2016. PMID: 27133223 Free PMC article.
Clinical efficacy and safety of first-line nilotinib or imatinib therapy in patients with chronic myeloid leukemia-Nationwide real life data.
Belohlavkova P, Zackova D, Klamova H, Faber E, Karas M, Stejskal L, Cmunt E, Cerna O, Jeziskova I, Machova Polakova K, Zak P, Jurkova T, Chrapava M, Mayer J. Belohlavkova P, et al. Among authors: faber e. Cancer Med. 2024 Sep;13(17):e70158. doi: 10.1002/cam4.70158. Cancer Med. 2024. PMID: 39267544 Free PMC article.
Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression.
Vráblová L, Klamová H, Skoumalová I, Navrátilová J, Janská R, Grohmann J, Holzerová M, Faber E. Vráblová L, et al. Among authors: faber e. Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S171-S181. doi: 10.1016/j.htct.2024.03.010. Epub 2024 Jul 22. Hematol Transfus Cell Ther. 2024. PMID: 39079797 Free PMC article.
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial.
Efficace F, Mahon FX, Richter J, Piciocchi A, Cipriani M, Nicolini FE, Mayer J, Zackova D, Janssen JJWM, Panayiotidis P, Vestergaard H, Koskenvesa P, Almeida A, Hjorth-Hansen H, Martinez-Lopez J, Olsson-Strömberg U, Hochhaus A, Berger MG, Etienne G, Klamova H, Faber E, Rousselot P, Pfirrmann M, Saussele S. Efficace F, et al. Among authors: faber e. Leukemia. 2024 Aug;38(8):1722-1730. doi: 10.1038/s41375-024-02341-4. Epub 2024 Jul 10. Leukemia. 2024. PMID: 38987274
249 results